82 related articles for article (PubMed ID: 29851232)
1. Hepatitis C among vulnerable populations: A seroprevalence study of homeless, people who inject drugs and prisoners in London.
Aisyah DN; Shallcross L; Hayward A; Aldridge RW; Hemming S; Yates S; Ferenando G; Possas L; Garber E; Watson JM; Geretti AM; McHugh TD; Lipman M; Story A
J Viral Hepat; 2018 Nov; 25(11):1260-1269. PubMed ID: 29851232
[TBL] [Abstract][Full Text] [Related]
2. Correlates of Hepatitis C Virus Infection in the Targeted Testing Program of the New York City Jail System.
Akiyama MJ; Kaba F; Rosner Z; Alper H; Kopolow A; Litwin AH; Venters H; MacDonald R
Public Health Rep; 2017; 132(1):41-47. PubMed ID: 28005477
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus infection in San Francisco's HIV-infected urban poor.
Hall CS; Charlebois ED; Hahn JA; Moss AR; Bangsberg DR
J Gen Intern Med; 2004 Apr; 19(4):357-65. PubMed ID: 15061745
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for hepatitis C virus infection among homeless adults.
Nyamathi AM; Dixon EL; Robbins W; Smith C; Wiley D; Leake B; Longshore D; Gelberg L
J Gen Intern Med; 2002 Feb; 17(2):134-43. PubMed ID: 11841529
[TBL] [Abstract][Full Text] [Related]
5. A descriptive study of hepatitis C in people who inject drugs.
Shivaprakash P; Patel V; Shadakshari D; Verma R; Shukla L; Mahadevan J; Kandasamy A; Chand PK; Benegal V; Sethuraman L; Sharma P; Murthy P
Indian J Med Res; 2023 Nov; 158(5&6):559-564. PubMed ID: 38084934
[TBL] [Abstract][Full Text] [Related]
6. Incidence of hepatitis C infection among prisoners by routine laboratory values during a 20-year period.
Marco A; Gallego C; Caylà JA
PLoS One; 2014; 9(2):e90560. PubMed ID: 24587394
[TBL] [Abstract][Full Text] [Related]
7. The estimated hepatitis C seroprevalence and key population sizes in San Diego in 2018.
Wynn A; Tweeten S; McDonald E; Wooten W; Lucas K; Cyr CL; Hernandez M; Ramirez F; VanWormer C; Suckow S; Ramers CB; Martin NK
PLoS One; 2021; 16(6):e0251635. PubMed ID: 34106932
[TBL] [Abstract][Full Text] [Related]
8. Health-Related Quality of Life of People Who Inject Drugs: The Enhancing Treatment of Hepatitis C in Opioid Substitution Settings Engage Study.
Cheng Q; Valerio H; Cunningham EB; Shih STF; Silk D; Conway A; Treloar C; Murray C; Henderson C; Amin J; Read P; Dore GJ; Grebely J;
Value Health; 2024 Feb; 27(2):216-225. PubMed ID: 37951538
[TBL] [Abstract][Full Text] [Related]
9. Barriers and facilitators to hepatitis C (HCV) screening and treatment-a description of prisoners' perspective.
Crowley D; Van Hout MC; Lambert JS; Kelly E; Murphy C; Cullen W
Harm Reduct J; 2018 Dec; 15(1):62. PubMed ID: 30538000
[TBL] [Abstract][Full Text] [Related]
10. 'I just keep thinking I haven't got it because I'm not yellow': a qualitative study of the factors that influence the uptake of Hepatitis C testing by prisoners.
Khaw FM; Stobbart L; Murtagh MJ
BMC Public Health; 2007 Jun; 7():98. PubMed ID: 17555573
[TBL] [Abstract][Full Text] [Related]
11. Barriers and advocacy needs for hepatitis C services in prisons: Informing the prisons hepatitis C advocacy toolkit.
Walker SJ; Shrestha LB; Lloyd AR; Dawson O; Sheehan Y; Sheehan J; Maduka NBC; Cabezas J; Akiyama MJ; Kronfli N;
Int J Drug Policy; 2024 Apr; 126():104386. PubMed ID: 38492433
[TBL] [Abstract][Full Text] [Related]
12. Impact of a positive hepatitis C diagnosis on homeless injecting drug users: a qualitative study.
Tompkins CN; Wright NM; Jones L
Br J Gen Pract; 2005 Apr; 55(513):263-8. PubMed ID: 15826432
[TBL] [Abstract][Full Text] [Related]
13. Innovative Approaches to Engaging Homeless and Marginally Housed Patients in Care: a Case Study of Hepatitis C.
Conti J; Dryden E; Fincke BG; Dunlap S; McInnes DK
J Gen Intern Med; 2023 Jan; 38(1):156-164. PubMed ID: 35879538
[TBL] [Abstract][Full Text] [Related]
14. HCV screening in a cohort of HIV infected and uninfected homeless and marginally housed women in San Francisco, California.
Page K; Yu M; Cohen J; Evans J; Shumway M; Riley ED
BMC Public Health; 2017 Feb; 17(1):171. PubMed ID: 28173785
[TBL] [Abstract][Full Text] [Related]
15. Incidence and prevalence of hepatitis C in prisons and other closed settings: results of a systematic review and meta-analysis.
Larney S; Kopinski H; Beckwith CG; Zaller ND; Jarlais DD; Hagan H; Rich JD; van den Bergh BJ; Degenhardt L
Hepatology; 2013 Oct; 58(4):1215-24. PubMed ID: 23504650
[TBL] [Abstract][Full Text] [Related]
16. Use of multiple data sources to estimate hepatitis C seroprevalence among prisoners: A retrospective cohort study.
Snow KJ; Richards AH; Kinner SA
PLoS One; 2017; 12(7):e0180646. PubMed ID: 28686715
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C seroprevalence among prison inmates since 2001: still high but declining.
Varan AK; Mercer DW; Stein MS; Spaulding AC
Public Health Rep; 2014; 129(2):187-95. PubMed ID: 24587554
[TBL] [Abstract][Full Text] [Related]
18. Seroepidemiological Investigation of Hepatitis B and C Prevalence and Associated Factors Among People in Custody at Zahedan Central Prison.
Metanat M; Almasi SZ; Sepehri Rad N; Tabatabaee SM; Rezaei K
Arch Iran Med; 2024 Jun; 27(6):298-304. PubMed ID: 38855799
[TBL] [Abstract][Full Text] [Related]
19. Rapid hepatitis C testing among persons at increased risk for infection--Wisconsin, 2012-2013.
Stockman LJ; Guilfoye SM; Benoit AL; Vergeront JM; Davis JP;
MMWR Morb Mortal Wkly Rep; 2014 Apr; 63(14):309-11. PubMed ID: 24717818
[TBL] [Abstract][Full Text] [Related]
20. [Hepatitis C in prisons : Treatment and barriers to the elimination goals of the United Nations].
Dichtl A; Jamin D; Stöver H; Grabski M; Knorr B
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2024 Jan; 67(1):36-44. PubMed ID: 38155308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
